Nevus of Ota, Hori's Nevus, and Café au Lait Spots: Why Blue-Gray Facial Birthmarks Usually Clear With Lasers While Flat Brown Ones Often Return, Why an Eye Exam Belongs Before the First Session, How Hori's Nevus Gets Mistaken for Melasma, and Which Pigmented Marks Should Be Cut Out Rather Than Lasered

The consultation usually opens with a sentence like this: "I have had this mark my whole life and I was told nothing could be done." Sometimes it is a blue-gray stain spreading from the temple across the cheek and onto the white of the eye. Sometimes it is a pair of gray-brown patches on the cheekbones that appeared in early adulthood and that three different clinics called melasma. Sometimes it is a flat, light brown oval on the jaw that a laser cleared once and that came back within a year. And sometimes it is a dark, raised mole that someone has offered to "laser off" in twenty minutes.

All four involve melanin, the same pigment that makes a tan, a freckle, or a sun spot. What separates them is where the pigment sits and which cells are making it. Pigment in the epidermis, the thin top layer of skin, looks brown. Pigment deeper in the dermis looks blue or gray, because of the way light scatters on its way back out of the skin (the same optical effect that makes a deep vein look blue). That single fact, depth, explains most of what follows: which lasers work, how many sessions they take, how often the mark returns, and which marks should not be treated with a laser at all.

This piece covers the pigmented birthmarks and birthmark-like marks that bring people to cosmetic dermatologists and plastic surgeons: the nevus of Ota and its relatives, Hori's nevus, café au lait macules, Becker's nevus, and congenital moles. It explains how lasers treat them, why outcomes differ so much between types, and where the medical questions (eye pressure, neurofibromatosis, melanoma) need answers before any cosmetic plan. It is general information, not a diagnosis. Any pigmented mark that is changing in size, shape, or color deserves a dermatology exam first. Vascular birthmarks, the red and purple ones, are a different subject covered in the piece on hemangiomas in adults.

What a nevus of Ota is, and why the eye exam comes before the laser

The short answer: a nevus of Ota is a patch of pigment-producing cells trapped in the deep layer of the skin, usually around one eye, the temple, the forehead, and the cheek, and because it often extends onto the white of the eye and is linked to a higher risk of glaucoma and, rarely, melanoma of the eye, anyone who has one needs an ophthalmology exam regardless of whether they ever treat the skin.

The mark was first described in 1939 by the Japanese dermatologist Masao Ota, and it is far more common in people of East Asian descent, with estimates in Japanese populations of roughly a fraction of one percent. It also occurs in people of South Asian, African, and Latin American descent and, less often, in white patients. Women are affected several times more often than men.

The term doctors use is dermal melanocytosis. Melanocytes, the cells that make pigment, normally migrate during fetal development from the neural crest to the top layer of skin. In a nevus of Ota, some of them stop partway, in the dermis, and keep producing pigment there. The pattern follows the first and second branches of the trigeminal nerve, which supply the forehead, the area around the eye, the cheek, and the side of the nose. Most cases are on one side; a minority are on both.

The timing tends to fall into two windows. Many marks are present at birth or appear in the first year of life. A second group appears around puberty, and some darken further during pregnancy, which points to a hormonal influence. The color ranges from brown to slate gray to blue-black, and it often looks mottled rather than uniform.

The eye is the part that turns a cosmetic question into a medical one. In a large share of people with a nevus of Ota, the pigment also involves the sclera (the white of the eye), where it looks like a gray or blue smudge. Pigment can extend deeper, into structures inside the eye. Published case series have reported glaucoma in roughly one in ten people with ocular involvement, and there is a small but real increased risk of uveal melanoma, a cancer that arises inside the eye. Both can develop silently. That is why the standard recommendation is an exam by an ophthalmologist, including eye pressure measurement, at diagnosis and then periodically for life. The exam has nothing to do with whether the skin is treated, and no laser treats the pigment in the eye.

Two relatives are worth knowing by name. A nevus of Ito is the same condition on the shoulder, side of the neck, and upper arm, following different nerves, and it is treated the same way. The common blue-gray patch over the lower back and buttocks of many babies, called congenital dermal melanocytosis and long known by an older, outdated name, usually fades during early childhood. Patches that persist, or that sit in unusual places, can be treated with the same lasers later. (Parents of children with these patches are sometimes advised to have them documented by a pediatrician, because they are occasionally mistaken for bruises.)

How Q-switched and picosecond lasers clear dermal pigment, and why it takes a long series

The short answer: lasers that fire extremely short pulses at wavelengths melanin absorbs can shatter pigment deep in the dermis without destroying the skin above it, and a nevus of Ota is one of the most reliable responders in laser dermatology, but clearing it typically takes a series of sessions spread over a year or more, with each round spaced months apart.

The principle is called selective photothermolysis, described by the Harvard researchers Rox Anderson and John Parrish in 1983: choose a wavelength the target absorbs and a pulse short enough that the heat stays in the target rather than spreading to the tissue around it. Pigment granules are tiny, so the pulse has to be tiny too. Q-switched lasers deliver pulses in nanoseconds (billionths of a second); picosecond lasers deliver them in trillionths. The pigment fractures into fragments small enough for the body's scavenger cells to carry away over the following weeks.

This is the same physics used to remove tattoos, and a nevus of Ota behaves much like a deep, evenly spread tattoo. The tradeoffs described in the piece on laser tattoo removal and scarring risks apply here: aggressive settings or sessions packed too close together raise the risk of scarring and texture change without clearing the mark any faster.

The wavelengths in common use are:

• Q-switched ruby (694 nm). Strongly absorbed by melanin and effective, but with a higher rate of temporary and sometimes lasting light spots, especially in darker skin.
• Q-switched alexandrite (755 nm). A middle option, widely used for dermal pigment.
• Q-switched Nd:YAG (1064 nm). Penetrates deepest and is absorbed less by the pigment in the top layer, which makes it the usual choice for medium and darker skin tones.
• Picosecond lasers (755, 1064, and other wavelengths). Several studies suggest comparable or faster clearance with fewer sessions, though head-to-head data are still limited, and the device does not change the fact that it is a series.

What the course looks like: sessions are commonly spaced around two to three months apart, sometimes longer, because the body clears fragments slowly and treating again before that work is done adds injury without adding benefit. Published series have commonly reported several sessions, often somewhere between four and ten, to reach substantial clearance, with more for darker, bluer, or more extensive marks. Children tend to need fewer sessions than adults, which is one reason some specialists favor starting earlier, with appropriate anesthesia for the eyelid area. After each session the area looks gray-white, then swells and may crust lightly for about a week.

The realistic expectations: many people reach marked lightening, and a meaningful share reach near-complete clearance. Recurrence after successful treatment has been reported but appears uncommon, sometimes years later. The common side effects are temporary darkening of the treated skin (post-inflammatory hyperpigmentation), which is more frequent in deeper skin tones and usually fades over months, and lighter spots (hypopigmentation), which can be slow to recover and occasionally persist. Both are among the reasons the cautions in the piece on cosmetic procedures on deeper skin tones apply, and why a test spot on a less visible area is common practice.

Two practical notes. Anyone who has taken isotretinoin recently should discuss timing, a question covered in the piece on the isotretinoin waiting period before procedures. And the laser cannot treat the eyelid margin or the white of the eye; protective eye shields are used during every session near the orbit, and the pigment on the eye itself stays.

"Brown means the pigment is near the surface, and blue or gray means it is deep. That one fact predicts more about a pigmented birthmark's response to a laser than the brand of the machine."

Hori's nevus versus melasma: the misdiagnosis that changes everything

The short answer: Hori's nevus is a form of deep dermal pigment that appears in adulthood as gray-brown patches on both cheekbones and often looks just like melasma, but it responds to the same pigment lasers as a nevus of Ota, while melasma tends to flare with aggressive laser treatment, so getting the diagnosis right decides whether lasers help or hurt.

The condition was described by the Japanese dermatologist Hori and colleagues in 1984, and it has a clumsy formal name, acquired bilateral nevus of Ota-like macules (sometimes abbreviated ABNOM). It most often affects women of East Asian descent and typically appears between the late teens and the forties. The patches are small, gray-brown to blue-gray, and speckled or confluent, most often on the cheekbones, and also on the temples, the lower eyelids, the bridge, and the sides of the nose. Unlike a nevus of Ota, it is on both sides from the start, appears in adulthood, and does not involve the eye.

Melasma is the most common wrong label. Both are bilateral, both favor the cheeks of women in the same age range, and both can darken with sun and hormones. And the two often coexist on the same face. The differences a trained eye looks for:

• Color. Melasma is usually tan to brown with fairly even edges. Hori's nevus tends to have a gray or bluish cast and a dotted texture.
• Location. Melasma commonly involves the forehead, upper lip, and central face in broad patches. Hori's nevus favors the cheekbones and the lower lids in smaller, speckled clusters.
• Behavior. Melasma fluctuates noticeably with sun exposure and season. Hori's nevus is steadier.
• Under a Wood's lamp or dermoscopy. Epidermal melasma looks more pronounced under the lamp; dermal pigment does not. Dermoscopy can show the bluish-gray dots of deep pigment.

Why it matters: melasma is a chronic, relapsing condition driven by sunlight, hormones, and inflammation, and the treatments that work are mostly gentle and long-term, as the piece on melasma treatment explains. High-energy laser treatment can make melasma rebound darker. Hori's nevus, by contrast, is deep pigment that topical creams cannot reach. Someone with Hori's nevus who has spent years on lightening creams and gentle peels may see no change because the pigment is beyond their reach, and someone with melasma who is treated like a nevus of Ota may end up worse.

When both are present, many specialists treat the melasma first, with sun protection and topical therapy, before beginning a cautious laser series for the dermal component. Post-inflammatory hyperpigmentation after laser is particularly common with Hori's nevus, often in a large share of patients, so the plan usually includes pre- and post-treatment pigment control and longer intervals between sessions. Hori's nevus on the lower lids is also a classic hidden cause of the gray-brown shadow described in the piece on under-eye dark circles, which is why a circle that does not respond to filler or creams deserves a closer look at the pigment.

Café au lait spots and Becker's nevus: why surface pigment is less predictable

The short answer: café au lait macules and Becker's nevus are pigmented birthmarks that sit mainly in the top layer of skin, and although lasers can lighten them, results are inconsistent and the color often returns, so a test spot comes before any full treatment, and six or more café au lait spots of a certain size call for a neurofibromatosis evaluation first.

Café au lait macules are flat, evenly colored, light-to-medium brown patches, named for the color of coffee with milk. A single spot is common in the general population and usually means nothing. Multiple spots are different. The diagnostic criteria for neurofibromatosis type 1 (NF1), a genetic condition that also causes benign nerve tumors and other problems, include six or more café au lait macules larger than 5 millimeters across before puberty or larger than 15 millimeters after puberty. A spot with very jagged edges, in a particular distribution, can also point to McCune-Albright syndrome. An adult who has several large spots and has never been evaluated should see a dermatologist or geneticist before treating any of them, both for their own health and because the diagnosis has implications for family members.

Treatment is where café au lait spots differ sharply from a nevus of Ota. The pigment sits mostly in the epidermis, where lasers reach it easily, and the spot often lightens or vanishes after one or two sessions. The problem is what happens next. In a substantial share of patients, the color comes back over the following months, sometimes patchily, sometimes completely. Published series have reported wide ranges of clearance and recurrence, from excellent results in some patients to nearly total relapse in others, and nobody can reliably predict in advance which outcome a given spot will have. Some studies suggest that spots with irregular borders respond more durably than those with smooth borders, but the evidence is not strong enough to promise anything.

The working approach is a test spot on a portion of the macule, followed by months of observation before deciding whether to treat the rest. The wavelengths used are typically Q-switched or picosecond lasers at shorter wavelengths, such as 532 nm, that target superficial pigment, along with ruby and alexandrite lasers; this is the same family of devices used on sun spots, as discussed in the piece on lasers for sun spots and pigmentation, with the important difference that a sun spot does not have a genetic tendency to repigment. Chemical peels and creams generally do little for a café au lait spot, for reasons covered in the piece on laser versus chemical peel.

Becker's nevus is the other common surface-pigment birthmark. It typically becomes noticeable around adolescence, most often in boys and young men, as a large, irregular brown patch on one shoulder, the upper chest, or the upper back, and it frequently grows coarse, dark hair. It is driven partly by androgen sensitivity, which explains the timing and the hair. Occasionally it comes with underdevelopment of the breast or chest muscle on the same side, a combination called Becker nevus syndrome, which is relevant to anyone considering chest or breast surgery on that side.

The two components of a Becker's nevus are treated separately. The hair responds well to laser hair removal, with the realistic expectations explained in the piece on laser hair removal as permanent reduction. The pigment is harder. Q-switched and picosecond lasers produce variable lightening with frequent recurrence, and some clinicians have reported better results with fractional resurfacing, the approach compared in the piece on ablative versus non-ablative laser resurfacing, though with more downtime and texture risk. For adolescents, the considerations in the piece on cosmetic procedures for teenagers, including waiting until the mark has stopped changing, are worth weighing.

Moles you were born with: when a laser is the wrong tool

The short answer: congenital moles and other melanocytic nevi are made of clusters of pigment cells, not just pigment, and lasering them is widely discouraged because it can leave cells behind, make a recurrence look like melanoma, and destroy the tissue a pathologist would need to tell the difference, so the standard approach for a mole that bothers someone is surgical removal with a pathology report.

This is the most important distinction in the whole subject. The marks in the earlier sections are either cells misplaced in the deep skin (Ota, Ito, Hori) or excess pigment in normal-looking skin (café au lait, Becker's). A mole, medically a melanocytic nevus, is a growth made of nest-forming pigment cells. Congenital moles are present at birth or appear in the first months of life, and they are classified by their projected adult size: small, medium, large, and giant. The melanoma risk associated with congenital moles is concentrated in the large and giant categories, those projected to exceed about 20 centimeters in adulthood, and is low for small ones. Large congenital nevi are managed by specialist teams, sometimes with serial excision or tissue expansion, and the decision is medical as much as cosmetic.

For an ordinary mole, the problem with a laser is that it fades the visible pigment while leaving nest cells deeper down. If the mole regrows, it can look irregular and alarming under the microscope, a pattern pathologists call a recurrent or pseudomelanoma nevus, and a clinician looking at the regrowth may not be able to tell whether it is benign without a biopsy. Worse, if the original mole was in fact an early melanoma, the laser destroyed the evidence and the cancer may have been left behind. Dermatology organizations, including the American Academy of Dermatology, advise that moles be examined, and that a mole removed for any reason be sent for pathology. The options for doing that cleanly, shave removal versus full excision, are compared in the piece on cosmetic mole removal.

A few related marks are worth sorting out. A speckled lentiginous nevus (also called nevus spilus) is a café au lait-like patch dotted with darker mole-like specks; the background responds like a café au lait spot, the specks behave like moles, and these patches warrant periodic monitoring. Raised brown growths that appear in midlife are usually seborrheic keratoses, not birthmarks, and are covered in the piece on seborrheic keratoses and benign growth removal. And any pigmented spot that is new in adulthood and changing, especially one that is asymmetric, multicolored, or growing, needs a dermatologist rather than a laser. If a melanoma or other skin cancer is found on the face, the reconstruction questions are the ones discussed in the piece on Mohs reconstruction for facial skin cancer.

Choosing who treats a pigmented birthmark follows from all of this. Dermal pigment, café au lait spots, and Becker's nevus are usually treated by dermatologists or plastic surgeons with substantial pigment-laser experience, and the treating physician should be the one who makes the diagnosis. A laser series performed under remote supervision, the arrangement described in the piece on who is injecting you at a med spa, is a poor fit for marks where the diagnosis is the whole game. The credential questions in the piece on board certifications apply, and the most useful thing to ask for is a set of before and after photographs of the specific mark type in skin like yours, read with the caveats in the piece on before and after photo consent.

For people who prefer not to treat at all, or who are waiting between sessions, camouflage cosmetics designed for full coverage can hide even dark blue-gray pigment, with the color-correcting principles covered in the piece on makeup after surgery and camouflage timing. This is not a lesser choice. For many people, a mark that has been part of their face for decades is simply part of their face.

The honest summary

Pigmented birthmarks share a pigment but not a biology, and the depth of that pigment predicts most of what lasers can do. A nevus of Ota, deep blue-gray pigment around the eye and cheek, is one of the most dependable responders in laser dermatology, but clearing it takes a long series of Q-switched or picosecond sessions spaced months apart, with temporary darkening and lighter spots as the main risks, especially in deeper skin tones. It also calls for a lifelong relationship with an ophthalmologist, because the same pigment often reaches the eye, where it raises the risk of glaucoma and, rarely, melanoma, and no laser touches it.

Hori's nevus is deep pigment that appears in adulthood on both cheekbones and is often mislabeled as melasma. The distinction decides the plan: Hori's nevus responds to the lasers used on a nevus of Ota, while melasma can flare under them. When both are present, the melasma is usually controlled first.

Café au lait spots and Becker's nevus sit near the surface. Lasers lighten them readily, but the color often returns, so a test spot and patience come before a full series, and several large café au lait spots call for a neurofibromatosis evaluation before any cosmetic treatment. Moles, including the ones people are born with, are a different category altogether: they are growths of pigment cells, and the responsible way to remove one is surgically, with a pathology report, not with a laser that erases the evidence.

A consultation for a pigmented mark that does not include a careful look at the mark, a question about when it appeared, and, near the eye, a question about the last eye exam is a consultation worth repeating, as the piece on getting a second consultation argues for any plan that skips the diagnosis. Most of these marks are benign and treatable. The order matters: what it is first, what it risks second, and what it will look like after the laser last.